3
IRUS TotalDownloads
Altmetric
Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis
File | Description | Size | Format | |
---|---|---|---|---|
s41385-020-0322-6.pdf | Published version | 3.17 MB | Adobe PDF | View/Open |
Title: | Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis |
Authors: | Du Bruyn, E Ruzive, S Lindestam Arlehamn, CS Sette, A Sher, AF Barber, DL Wilkinson, RJ Riou, CR |
Item Type: | Journal Article |
Abstract: | Recent data from mice and non-human primate models of tuberculosis suggested that CD153, a TNF super family member, plays an important role in Mycobacterium tuberculosis (Mtb) control. However, this molecule has not been comprehensively evaluated in humans. Here, we show that the proportion of Mtb-specific CD4 T cells expressing CD153 was significantly reduced in active TB patients compared to latently infected persons. Importantly, the CD153+ Mtb-specific CD4 response inversely correlated with lung bacterial load, inferred by Xpert cycle threshold, irrespective of HIV status. Antitubercular treatment partially restored CD153 expression on Mtb-specific CD4 T cells. This is the first report of a subset of Mtb-specific CD4 T cells showing strong negative correlation with bacterial burden. Building on substantial evidence from animal models implicating CD153 as a mediator of host protection, our findings suggest it may play a similar role in humans and its measurement may be useful to evaluate TB vaccine efficacy. |
Issue Date: | 1-Mar-2021 |
Date of Acceptance: | 23-Jun-2020 |
URI: | http://hdl.handle.net/10044/1/81368 |
DOI: | 10.1038/s41385-020-0322-6 |
ISSN: | 1933-0219 |
Publisher: | Springer Nature [academic journals on nature.com] |
Start Page: | 491 |
End Page: | 499 |
Journal / Book Title: | Mucosal Immunology |
Volume: | 14 |
Copyright Statement: | © 2020 The authors. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
Sponsor/Funder: | Wellcome Trust European and Developing Countries Clinical Trial Partnership European and Developing Countries Clinical Trials Partnership EDCTP Wellcome Trust |
Funder's Grant Number: | 104803/Z/14/Z SRIA2015-1065 SRIA2015-1065 RIA2017T-2004 WDAI_P83556 |
Keywords: | Science & Technology Life Sciences & Biomedicine Immunology NATURAL-KILLER-CELLS XPERT MTB/RIF ASSAY IFN-GAMMA NK CELLS HIV INFECTION ACTIVATION MEMBERS FAMILY SCORE Immunology 06 Biological Sciences 11 Medical and Health Sciences |
Publication Status: | Published |
Online Publication Date: | 2020-07-16 |
Appears in Collections: | Department of Infectious Diseases Faculty of Medicine |
This item is licensed under a Creative Commons License